Lipum AB Current Valuation vs. Total Debt
| LIPUM Stock | SEK 14.30 1.90 11.73% |
For Lipum AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Lipum AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Lipum AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Lipum AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Lipum AB over time as well as its relative position and ranking within its peers.
Lipum |
Lipum AB Total Debt vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Lipum AB's current stock value. Our valuation model uses many indicators to compare Lipum AB value to that of its competitors to determine the firm's financial worth. Lipum AB is rated fifth overall in current valuation category among its peers. It is considered the number one company in total debt category among its peers making up about 0.02 of Total Debt per Current Valuation. The ratio of Current Valuation to Total Debt for Lipum AB is roughly 62.64 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lipum AB's earnings, one of the primary drivers of an investment's value.Lipum Current Valuation vs. Competition
Lipum AB is rated fifth overall in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is now estimated at about 926.13 Million. Lipum AB retains roughly 98.1 Million in current valuation claiming about 11% of stocks in Biotechnology industry.
Lipum Total Debt vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Lipum AB |
| = | 98.1 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Lipum AB |
| = | 1.57 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Lipum Total Debt vs Competition
Lipum AB is considered the number one company in total debt category among its peers. Total debt of Biotechnology industry is now estimated at about 2.12 Million. Lipum AB totals roughly 1.57 Million in total debt claiming about 74% of stocks in Biotechnology industry.
Lipum AB Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Lipum AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Lipum AB will eventually generate negative long term returns. The profitability progress is the general direction of Lipum AB's change in net profit over the period of time. It can combine multiple indicators of Lipum AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Lipum AB , a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company was founded in 2010 and is headquartered in Ume, Sweden. Lipum AB is traded on Stockholm Stock Exchange in Sweden.
Lipum Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Lipum AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Lipum AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Lipum AB's important profitability drivers and their relationship over time.
Use Lipum AB in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lipum AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipum AB will appreciate offsetting losses from the drop in the long position's value.Lipum AB Pair Trading
Lipum AB Pair Trading Analysis
The ability to find closely correlated positions to Lipum AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lipum AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lipum AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lipum AB to buy it.
The correlation of Lipum AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipum AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipum AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lipum AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Lipum AB position
In addition to having Lipum AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Lipum Stock Analysis
When running Lipum AB's price analysis, check to measure Lipum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipum AB is operating at the current time. Most of Lipum AB's value examination focuses on studying past and present price action to predict the probability of Lipum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipum AB's price. Additionally, you may evaluate how the addition of Lipum AB to your portfolios can decrease your overall portfolio volatility.